Dominik Witzigmann

Dominik Witzigmann

Company: Nanovation Therapeutics

Job title: Co-Founder & Chief Executive Officer

Seminars:

Closing Remarks & End of Day One 4:45 pm

Read more

day: Day One

Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery 11:40 am

VIRTUAL PRESENTATION Platform technologies tailored to a variety of tissues Improved potency and safety Scalable, nucleic acid agnostic, based on GRAS substancesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.